Confocal imaging of changes in glial calcium dynamics and homeostasis after mechanical injury in rat spinal cord white matter.
Periaxonal glia play an important role in maintaining axonal function in white matter. However, little is known about the changes that occur in glial cells in situ immediately after traumatic injury. We used fluo-3 and confocal microscopy to examine the effects of localized (<0.5 mm) mechanical trauma on intracellular calcium (Ca(i)(2+)) levels in glial cells in a mature rat spinal cord white matter preparation in vitro. At the injury site, the glial Ca(i)(2+) signal increased by 300-400% within 5 min and then irreversibly declined indicating cell lysis and death. In glial cells at sites adjacent to the injury (1.5-2 mm from epicenter), Ca(i)(2+) levels peaked at 10-15 min, and thereafter declined but remained significantly above rest levels. At distal sites (6-9 mm), Ca(i)(2+) levels rose and declined even slower, peaking at 80-90 min. Injury in zero calcium dampened Ca(i)(2+) responses, indicating a role for calcium influx in the generation and propagation of the injury-induced Ca(i)(2+) signal. By 50-80 min post-injury, surviving glial cells demonstrated an enhanced ability to withstand supraphysiological Ca(i)(2+) loads induced by the calcium ionophore A-23187. Glial fibrillary acidic protein (GFAP) and CNPase immunolabeling determined that the glial cells imaged with fluo-3 included both astrocytes and oligodendrocytes. These data provide the first direct evidence that the effects of localized mechanical trauma include a glial calcium signal that can spread along white matter tracts for up to 9 mm within less than 3 h. The results further show that trauma can enhance calcium regulation in surviving glial cells in the acute post-injury period.
Mills
Linda R
LR
Division of Cellular and Molecular Biology, The Toronto Western Hospital Research Institute, University Health Network, Toronto, Canada. linda@uhnres.utoronto.ca
Velumian
Alexander A
AA
Agrawal
Sandeep K
SK
Theriault
Elizabeth
E
Fehlings
Michael G
MG
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000814:Aniline Compounds; D000818:Animals; D001253:Astrocytes / Q000502:physiology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000502:physiology*; D016923:Cell Death; D002470:Cell Survival; D005260:Female; D005456:Fluorescent Dyes; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006706:Homeostasis / Q000502:physiology*; D007150:Immunohistochemistry; D007476:Ionophores / Q000494:pharmacology; D018613:Microscopy, Confocal; D009457:Neuroglia / Q000473:pathology / Q000502:physiology*; D009836:Oligodendroglia / Q000502:physiology; D011188:Potassium / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013119:Spinal Cord Injuries / Q000473:pathology / Q000503:physiopathology*; D014966:Xanthenes
D000814:Aniline Compounds; D005456:Fluorescent Dyes; D005904:Glial Fibrillary Acidic Protein; D007476:Ionophores; D014966:Xanthenes; C059715:Fluo-3; D000001:Calcimycin; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D011188:Potassium; D002118:Calcium